Company / Financials
Evolent Health, Inc. Financials
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$483.6M
FY2025 · -81.1% YoY
Net Income
-$64.6M
FY2025 · -4.9% YoY
Profit Margin
-13.4%
FY2025 · net income / revenue
ROE
-15.6%
FY2025 · return on equity
Total Assets
$1.9B
FY2025
Total Debt
$970.5M
2.34x debt/equity
Equity
$415.2M
FY2025
ROA
-3.4%
FY2025 · return on assets
Statement paths
Metric history
Revenue HistoryTotal revenue from operations$483.6M-81.1% YoYNet Income HistoryProfit after all expenses and taxes-$64.6M-4.9% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$1.5B-32.5% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$410.1M-913.1% YoYSG&A Expense HistorySelling, general, and administrative expenses$303.9M+15.5% YoYR&D Expense HistoryResearch and development spending-Interest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense-$126.0K+91.1% YoYEPS (Basic) HistoryBasic earnings per share-$1.28-540.0% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$1.28-540.0% YoY